Bionano Genomics Inc (BNGO) Inventory Turnover Ratio, from third quarter 2026 to third quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 
Bionano Genomics Inc   (NASDAQ: BNGO)
 

Bionano Genomics Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the third quarter 2026, Bionano Genomics Inc 's inventory turnover ratio sequentially decreased to 4.12 in the third quarter 2026, otherwise the ratio remained above the average, as BNGO's markets remain strong.Bionano Genomics Inc 's average inventory processing period in the Sep 30 2026 quarter, has increased to 89 days, from 40 days, in the Jun 30 2026 quarter.

Within Healthcare sector Bionano Genomics Inc achieved the highest inventory turnover ratio. While inventory turnover ranking remained unchanged in the Third Quarter 2026 compared to previous quarter at no. .

BNGO Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Bionano Genomics Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BNGO Inventory Turnover Ratio (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Inventory Growth - - - - -
Y / Y Cost of Sales Growth 8.26 % 18.46 % -2.39 % -4.11 % -72.47 %
Inventory Turnover Ratio (TTM) 4.12 9.03 - - -
BNGO's Total Ranking # # # # #
Average inventory processing period 89 40 - - -
Seq. Inventory Growth 24.01 % - - - -
Seq. Cost of Sales Growth 12.19 % 12.29 % -24.52 % 13.86 % 22.76 %




Inventory Turnover Ratio Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #
Healthcare Sector #
Overall Market #

Inventory Turnover Ratio Statistics
High Average Low
0 0 0
 



BNGO Company Profile >> Back to BNGO Efficiency Comparisons >> Compare BNGO Inventory Turnover Ratio to its Competitors

Financial Statements
Bionano Genomics Inc 's Inventories $ 9 Millions Visit BNGO's Balance sheet
Bionano Genomics Inc 's Cost of Revenues TTM $ 16 Millions Visit BNGO's Income Statement
What are BNGO's Sales? Visit BNGO's Sales by Segment

Other Inventory Turnover Ratios
Bionano Genomics Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Laboratory Analytical Instruments Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
BNGO's Inventory Turnover Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for BNGO's Competitors
Inventory Turnover Ratio for BNGO's Suppliers
Inventory Turnover Ratio for BNGO's Customers

You may also want to know
BNGO's Sales Growth Rates BNGO's Pe Price to earnings ratio BNGO's Receivables Turnover Ratio BNGO's Stock Quote
BNGO's Net Income Growth Rates BNGO's Ps Price to Sales ratio BNGO's Sales per Employee BNGO's Asset Turnover Ratio
BNGO's Net Margin BNGO's Pb Price to Book ratio BNGO's Financial Strength Ratios BNGO's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2026 Inventories at quarter ending Sep 30 2026
Integer Holdings Corporation  4.98 $ 1,376.268  Millions$ 276  Millions
Ge Healthcare Technologies Inc   4.69 $ 11,372.000  Millions$ 2,425  Millions
West Pharmaceutical Services Inc   4.69 $ 2,120.200  Millions$ 452  Millions
Henry Schein Inc   4.63 $ 9,395.000  Millions$ 2,031  Millions
Cryoport inc   4.60 $ 102.157  Millions$ 22  Millions
Myomo Inc   4.58 $ 14.802  Millions$ 3  Millions
Idexx Laboratories Inc  4.52 $ 1,743.379  Millions$ 386  Millions
Autolus Therapeutics Plc  4.34 $ 88.293  Millions$ 20  Millions
Medinotec Inc   4.28 $ 5.143  Millions$ 1  Millions
Electromed Inc   4.18 $ 14.878  Millions$ 4  Millions
Intelligent Bio Solutions Inc   4.14 $ 2.206  Millions$ 1  Millions
3m Company  4.02 $ 15,267.000  Millions$ 3,801  Millions
Novocure Limited  3.98 $ 166.721  Millions$ 42  Millions
Sonoma Pharmaceuticals Inc   3.90 $ 14.275  Millions$ 4  Millions
Koru Medical Systems Inc   3.88 $ 16.831  Millions$ 4  Millions
Incyte Corporation  3.79 $ 439.399  Millions$ 116  Millions
Baxter International Inc   3.57 $ 8,117.000  Millions$ 2,277  Millions
Bausch Health Companies Inc   3.54 $ 4,518.000  Millions$ 1,276  Millions
Coherus Oncology inc   3.50 $ 16.193  Millions$ 5  Millions
Exelixis Inc   3.49 $ 93.324  Millions$ 27  Millions
Abbvie Inc   3.40 $ 17,346.000  Millions$ 5,108  Millions
Gilead Sciences Inc   3.30 $ 6,219.000  Millions$ 1,884  Millions
Iovance Biotherapeutics inc   3.21 $ 177.232  Millions$ 55  Millions
Teva Pharmaceutical Industries Limited  3.16 $ 8,011.000  Millions$ 2,537  Millions
Msa Safety Inc  3.00 $ 1,063.235  Millions$ 354  Millions
Mimedx Group Inc   2.98 $ 70.562  Millions$ 24  Millions
Abbott Laboratories  2.95 $ 20,765.000  Millions$ 7,032  Millions
Revvity Inc  2.93 $ 1,122.448  Millions$ 384  Millions
Ligand Pharmaceuticals Incorporated  2.93 $ 34.495  Millions$ 12  Millions
Zai Lab Limited  2.91 $ 200.083  Millions$ 69  Millions

Date modified: 2026-11-12T05:51:30+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.